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.I INTRODUCTION lr ,, 
II 
•I Hemolytic disease of the newborn is a disease qf the II 
II !I fetus and newborn characterized by anemia, splenomegaly, 
il hepatomegaly, erythroblastemia, and pallor which may be 
1/ I' 
'I evident or masked by a deepening jaundice. I! 
Three originally separate disease entities have been 
shown to be different manifestations of the same pathologi-
cal process. These three are hydrops fetalis, icterus 
gravis neonatorum, and congenital an~ia of the newborn. 
Blomfield (1) reported the occurrence of jaundice in 
three successive siblings who died soon after birth. 
Abt (2) remBrked about the familial occurrence of icterus 
with frequent sparing of the first one or two children. 
Segar and Stoeffler (3) reported anemia of the newborn in 
three successive siblings. Bullard and Plaut (4) reported 
a family in which two siblings died, one of icterus gravis, 
the other of fetal hydrops. Pasachoff and Wilson (5) 
•
111
,.
1
. reported the case of a mother who gave birth in turn to a 
nor.mal child, a child with congenital anemia, and two 
:r 
il 
il premature stillborns with fetal hydrops. A similarity in !' ,I 
II 
q 
!I 
the clinical pictures seen in the three condi tiona was noted i; 
:l 
!I 
ll ( 3, 6). 
I, Diamond, Blackfan, and Baty (7) reviewed the 
II " ·' i! I lr 
'I ][ literature, and, on the basis of the known familial tendency!i I: 
the differ- I[ 
'I 
+
:: in the three syndromes, the fact that cases of 
~ ent syndromes appeared in the same family, and 
-=-=~===- !' ==--"·'--=~--=~c_o-c~-----,,====~-,--~,==-~c- cc~c===~==--o-. -~- c - -,_- -,- on --~~-- basis_ ~=~=,=~ 
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2. 
of similar pathology and a similar hematologic picture, 
concluded that all three types are different manifestations 
of the same disease. 
Rautman (8) in 1912 introduced the name "Erythroblasto-
sis". In recent years, with the elucidation of the fun-
damental pathology of the disease, the name "Hemolytic 
Disease of the Newborn" has been suggested as a more proper 
designation of the condition (9, 10). As Wiener (11) has 
1 pointed out, erythroblastosis is not a constant feature, 
while hemolysis is. However, in the most recent literature, 
both names are used interchangeably, and they will be so 
used in this paper. 
-i!" 
ETIOLOGY 
Although the clinical and' pathological pictures of the · 
disease have been known for many years, the etiology was, 
until recently, unknown; and many divergent theories were 
offered to explain the pathogenesi~ of this disease. In 
1938, Darrow (12) presented an excellent critical analysis 
of the various theories. On the basis of the clinical, 
pathological, and laboratory findings; the usual sparing 
of the first-born; the health of the parents and the 
familial tendency; the association of the three clinical 
i types; and the apparent absence of a hereditary factor, she ' 
~ q 
established a set of criteria which must be met by any 
theory of etiology. She found the theories which had been 
proposed up to that time unable to satisfy her criteria and 
she concluded, "An antigen-antibody reaction seems to 
II 
explain best all aspects of these related disorders. 
In 1939, Levine and Stetson (13) reported the case of 
a woman, recently delivered of a macerated fetus, who 
received a blood transfusion from her husband. Both were 
group 0, yet a severe hemolytic transfusion reaction 
resulted. Her serum was shown to contain an atypical 
agglutinin which agglutinated so% of random 0 bloods tested. i: 
They postulated iso-~nization of the mother by a 
property in fetal blood or tissues which was inherited from 
1
1 the father as a dominant factor not present in the mother. 
li L. 
li In 1940, ~andsteiner and Wiener (14) reported that 
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immune serum produced by injecting rabbits with the blood 
of the Rhesus monkey agglutinated the blood of 39 out of 45 
people selected at random. They called the agglutinogen 
involved the Rh factor because of its occurrence in the 
Rhesus monkey. People whose erythrocytes contain this 
agglutinogen are called Rh+, those whose erythrocytes do not 
contain the agglutinogen are Rh-. 
Levine and his coworkers noticed a high incidence of 
toxemia, spontaneous abortion, stillbirths, neonatal death, 
and infants with erythroblastosis fetalis in women who got 
intra-group hemolytic transfusion reactions and in whose 
blood atypical agglutinins were found (15, 16). In the 
great majority of cases, the mothers were Rh-, the husbands 
and infants were Rh+, and the atypical agglutinins, if 
present, paralleled that of Landsteiner and Wiener. 
Levine, Katzin, and Burnham (15) proposed a theory of 
Pathogenesis of erythroblastosis fetalis. 
, two fundamental processes are involved: 
According to them,[: 
!: 
1. The iso-immunization of the mother by a 
dominant hereditary blood factor in the fetus 
inherited from the father with the production of 
intragroup agglutinins. 
2. The subsequent continuous passage of these 
agglutinins from the maternal circulation across 
the placental barrier and their action on the 
fetal blood. 
5. 
Proof of the validity of their theory accumulated rapidly. 
Levine et al (17) produced convincing statistical 
evidence in support of their theory. 
it 
They tabUlated~as follows: 
Rh -r Rh-
,, Random population 
Males (829) 
Females (206) 13.8%:: 11.6 ll 
111 mothers of infants with erythroblastosis 
fetalis 
66 husbands of Rh- mothers 
58 affected infants 
100.0 
100.0 
91.0 
Atypical agglutinins were found in the mothers' blood 
in about 5Q% of oases when they were tested within two 
months after delivery. 
Boorman, Dodd, and Mollison (18) soon oonfirn1ed these 
findings. Out of 1610 people tested 85.15% were found to be i: 
1: 
RhT, yet of 48 mothers of infants with hemolytic disease of 
the newborn, 46 were Rh-. All 48 infants were R~. 44 of 
the mothers had demonstrable anti-Rh agglutinins in their 
sera. Race et al (19) reported that of 50 mothers of 
affected infants, 44 were Rh-. 
anti-Rh agglutinins were found. 
of Rh- mothers was Rh-. 
1: In 38 of these, demonstrable ii 
d None of the affected infant~ 
•' 
These findings are significant enough statistically so 
that, in borderline cases, a diagnosis of hemolytic disease 
of the newbern can be made on the typical findings of an 
; 
11 
Rh-r- father and fetus and an Rh- mother (20). 1/ 
II Further evidence in support of the theory of iso- l1 ~~~"~C~-inmlu!l1~a~c1~n~ is :found in the relationshipbe_tyteen hemolytic l~-----
11 
il 
I' 
,; 
i: 
6 
disease of the newborn and transfusions. In the typical 
obstetrical history in a woman who gives birth to an 
affected infant, the first one or two infants born are 
normal, even though they may be Rh~. Then succeeding Rh+ 
infants are affected by hemolytic disease of varying degrees : 
II of severity. (21) This is due to the fact that more than one 
II 
'I 
:I pregnancy w1 th an Rh-r fetus is usually necessary to induce 
!I 
!i a sufficient degree of iso-immunization in the mother to 
rl I! 
!I cause the disease in the infant (20). However, where the 
I! 
![ mother has already been sensitized by transfusion of Rh-+-
!i ,, 
)) 
1: 
blood, the first-born may suffer from very severe hemolytic 
disease of the newborn. Diamond (22) reported the case of 
an Rh- woman who had received 8 transfusions (untyped for 
Rh) the last two of which had caused hemolytic reactions. 
Later her first pregnancy resulted in the birth of a baby 
with severe hydrops. 
Further support of the theory is seen in the sparing 
of Rh- siblings. In a typical case, once hemolytic disease 
of the newborn has occurred in a family, subsequent RhT 
babies are all affected (23). The mother is restimulated 
to produce stronger agglutinins, and the disease tends to 
become increasingly severer in subsequent pregnancies, with: 
more jaundice and earlier int~auterine death with a picture 
of universal hydrops and anemia (21). Should a subsequent 
pregnancy result in the birth of an Rh- baby, however, it 
~ is spared and shows no evidence of the disease • 
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7. 
il This fact is further brought out by the incidence of 
fi the disease in twins. When the disease affects one of a set , 
of single-ovum twins, it always affects the other (24). 
Potter (25) reported the case of an Rh- woman who gave birth 11 !! 
to double-ovum twins. Both were RhT and both suffered from 
erythroblastosis. In ahother of her cases an Rh- woman gave 
birth to double-ovum twins; one of the twins was Rh- and 
perfectly normal; the other was Rh+ and developed 
erythroblastosis fetalis. Her second case was almost 
identical with that of Kariher•s (26) in which the woman 
had a history of two nor.mal children followed by a spontan-
eous abortion attwo and a half months, then this double 
pregnancy with hydramnios. Post-partum the serological 
findings were as follows: 
Father 
Mother 
Normal twin 
Twin with erythro-
blastosis fetalis 
Group 
A 
A 
A 
A 
Rh 
+ 
+ 
Anti-Rh 
+ 
Potter and Willson (27) present the case of an Rh- wama~ 
,I 
with an RhThusband, who had one nor.mal child, then a 
spontaneous abortion, then twins both of whom died of 
erythroblastosis (confirmed by autopsy). She was 
artificially inseminated from an Rh- donor and gave birth 
to a normal Rh- child. Diamond (21) reports 6 similar 
successful inseminations. 
Dameshek, Greenwait, and Tat (28), from their studies 
on fecal excretion of bilirubin and on the blood picture 
acute acquired hemolytic anemia on the basis of an 
agglutination-hemolysis reaction. Reisner (29) studied 
Price-Jones curves on the cord and peripheral blood of 24 
cases of hemolytic disease. 23 of these showed a typical 
bipbasic curve with either one normocytic and one 
macrocytic, or with two macrocytic peaks. These, he said, 
were very similar to the curve found in an experimental hemo~ 
lytic anemia due to an antigen-antibody reaction. 
Davidsohn (30) has shown very clearly the interrelationships 
among the various clinical and pathological manifestations 
of erythroblastosis fetalis and their probable pathogenesis 
on the basis of hemolysis ( fig. 1). 
Since the Rh factor is not present in body fluids and 
is probably limited to the red blood cells (1?), passage of 
' fetal red cells across the placental barrier in the 
pathogenesis of this disease is assumed (31). Placental 
lesions have been described and offered as the means where-
by fetal erythrocytes get into the maternal circulation. 
! Breaks in the placental barrier could occur due to trauma 
by fetal movements, partial separation, or placental 
infarcts with a break in the integrity of the villi (32). 
However, Levine (33), by animal experimentations, has 
estimated that only about o.i3 cc. of blood is necessary 
_to immunize the mother, so grossly detectable placental 
lesions need not be assumed. 
Fig, 1, Pathogenesis of Fetal Erythroblastosis 
III b. Obstructive __________________ ~ 
Jaundice 
t 
Intrahepatic 
Biliary Stasi 
t 
III a. Hemolytic 
~ Jaundice 
,----------~' . Extrame~ullary I II Erythroblastemia )~·Erythropoiesis 
- In Liver 
\III Icterus Gravis 
'\ 
III c. Hepatocellular 
Jaundice 
~! 
f' (decreased ~ (Pressure atrophy 
capacity)" and circulatory Macrocytic 
" ~ · diaturbanceo Anemia 
1 :::Utic ~ Anoxemiaq Ell~~hel~ .Edema I 
Damage 
i ~ 
Rh-Isohemolysins Purpura 
(Davidsohn, I: JAMA 127:633-8,1945) 
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: The occurrence of an Rh+ husband and an Rh- wife is 
seen in between 10 and 13~ of pregnancies (11,21,31). In 
recent years, the incidence of hemolytic disease of the 
newborn has been variously reported as one in 438 deliveries, 
(24), one in 370 deliveries (23), one in 200 births (31), 
and 1 in 150 births (21). Thus the disease occurs in only 
about 4 or 5% of those pregnancies in which it could readily, 
appear. Several explanations have been given for this low 
incidence: 
1. The modern tendency to small families is 
given as one cause. Since it has been shown that 
multiparity is an important factor in this disease, 
92% of Javert's cases having occurred in multi-
paras (24), restriction in the size of a family 
could either prevent the appearance of the disease 
or lower its incidence (31}. 
2. Some of the husbands are heterozygous 
for the Rh factor and thus have a 50% chance of 
siring a normal Rh- child (31). 
3. There is variation in the permeability 
of the placenta to fetal cells or to agglutinins 
(34). Potter (23) thinks that only in some 
pregnancies do the fetal red blood cells get into 
the maternal circulation. She considers this the 
most important factor in the low incidence of the 
It has been shown that the placental 
10. 
barrier varies in permeability in different 
women and in any one woman at different times (30). 
4. Some women don't produce anti-Rh 
antibodies in response to the antigenic stimulus 
of Rh+ blood. Wiener and Wexler (35) postulated 
that only 2 to 5% of the population will respond 
to Rh and other foreign iso-antigens by the 
production of specific iso-agglutinins. They 
offered evidence to show that people who produce 
anti-Rb also have a high incidence of multiple 
sensitization. Potter (36) also noted that one 
of the predisposing factors to the production of 
hemolytic disease of the newborn is a past or 
family history of asthma, bay fever, or other 
allergic manifestations. 
5. Variability in the antigenic potency 
of the Rh factor, and variation in the manner of 
response of the fetal tissues to the presence of 
the antibody have also been proposed as possible 
factors in the low incidence of the disease (36). 
Limitation in the size of families and the relation 
between anti-Rh production and atopic manifestations seem 
to be the most important factors in explaining the observed 
discrepancy. 
The typical findings of an Rh+ father and tetus and an 
Rb- mother were seen in more than 90% of the cases of ~ i I 
il 
-- ~~---= -:::-~--n 
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:i hemolytic disease of the newborn, but the occurrence of the 
/! disease in the fetuses of Rh+ mothers required explanation 
il to fit these cases into Levine's iso-immunization theory. 
I! 
il 
ij 
In some cases where the mother was Rb~, iso-immunization 
I' 
II was shown to be due to an Hr factor, closely related 
II 
" [i genetically to the Rh factor, with the production of anti-
'
lj 
1
, Hr agglutinins. and erythroblastosis fetalis (24,31). It was 
II 
1j soon realized that the Rh factor, far from being the simple 
li ji 
li agglutinogen reported by Lendsteiner and Wiener, was 
fi actually a mosaic of several different closely related 
ii 
il genetic factors, and that some cases of iso-immunization in 
I! 
'I 
l1 Rh+- mothers were due to a fraction of the Rh factor which ,, 
li 
il was present in the fetuses but absent in the mother (34). 
i! 
11 Wiener (3'7) reported a series of sucP. cases. 
!\ 
I II 
II 
ii il 
!i 
Polayes (38) reported that of 105 cases of erythroblas-i 
to sis fetalis, 6 were due to iso-inmnmization by the A and B ,, 
1[ factors in the blood. Careful checking ruled out the 
I, 
11 possibilitov- of immunization against any of the Rh factors. li ., 
p 
'I He compared the agglutinin titers in these women w1 th the 
!I 
11 titers found in two groups of eon trols. In a series of 
II nulliparous group 0 women he found an average anti-A titer 
I, of 58. In a series of parous group 0 women who had given 
[i birth to normal children, he found an average anti-A ti tar 
,I 
li of 215. In the group 0 Rh-+-women who had been delivered of 
j! infants w1 th erythroblastosis fetalis • the average anti-A i ~ j titer was '710. These women were all "non-seoretors". In II 
-~'. ==-====--1(=~~.-o~--~~--=· =~--= ----=-----= =-~=~~---=~---~=~~==-=-=---==--~=-=------- .. ~--·j! 
'I 
il 
il 
i! 
.~ ii 
I 
.• :! 
,, 
!: 
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' rare cases, iso-immunization may even be due to the M, N, 
and P factors of the blood (11). 
'i 
ii 
ii 
I! of pathogenesis was the lack of correlation between the 
!I 
I: 
One of the facts that failed to support Levine's theory 
severity of the disease in the fetus and the presence or 
" ii 
:r :, the titer of the anti-Rh agglutinin in the maternal 
i! 
,I 
ii 
'I 
lr 
circulation. Levine et al (1'7) found anti-Rh in only about;. 
i: 
:1 
5Q% of the mothers of erythroblastotic infants, and 
Da~dsohn (39) reported anti-Rh in 82 out of 152 mothers of 
affected infants. The latter pointed out that the ideal 
time to look for anti-Rh agglutinins in maternal serum was 
8 to 20 days postpartum, and he reported that a much higher 
percentage of mothers showed anti-Rh when their sera were 
examined at the ideal time. 
This lack of correlation between the severity of the 
disease and maternal Anti-Rh titer has been explained, at 
least partially, by the discovery of the "blocking antibody"~ 
;t 
!; 
Wiener (40,41) showed that many Rh- mothers of erythroblasto1 
!f 
tic infants have in their sera an anti-Rh antibody which 
specifically unites with and coats Rht cells. This antibody 
not only doesn't cause agglutination; it actually prevents 
agglutiuation of Rh~ cells in the presence of anti-Rh 
agglutinins. The "blocking antibody" is, however, equally 
as potent as the agglutinin in producing in vivo hemolysis 
ii (42). Thus the determination of the anti-Rh titer by the 
~ I! routine method of Rh agglutination gives no true index of 
~~ =~~~=,~=-~~-=c .. -=---~~---==~==-~=~--~- -==~~ -_ -~~~~~.c.·c ·- ~- --· - ''-·= 
il 
ii 
i! 
'i 
13. 
the actual strength of specific anti-Rh hemolysins present 
in the maternal serum. 
Anbther fact difficult to explain on the basis of 
Levine's theory is that the disease fre~uently becomes more 
severe after birth than it was in utero. If the disease is 
due to the action of antibodies constantly passing across 
the placental barrier and acting on the fetal cells, the i· 
·' 
pathological course would be expected to reach a peak at the :· 
il ,, 
end of uterine life and then take a turn for the better, 
after birth, with the cessation of antibody transfer from 
the maternal to the fetal circulation. 
/I. Potter (23) thought the increase in severity postpartum 
[i might be due to a non-specific abnormal exaggeration of the 
:1 
usual physiologic destruction of red cells seen in early 
neonatal life. Wiener and Wexler (35) postulated the 
following mechanism. In utero, the antibodies are stores 
:
1 
by fetal tissue cells which thus prevent a reaction with 
I! thejretal erythrocytes. Only when tissue saturation with [, 
li 
I> anti-Rh is reached, does hemolytic action on the red blood 
!I 
[f cells occur causing intra-uterine death. If saturation 
:: 
I! is not reached in utero, the infant is born apparently 
I! 
Jl normal; then for some unknown reason the tissues release 
li !I the antibodies. A reaction with the infant's red cells 
:j 
li then occurs, the spped of hemolysis and the severity of the 
I' 
1 resulting symptoms then being factors of the quantity of 
~ II antibodies storei and the speed with which their release 
-~-~--=====-==-t=~~==.c~-~·-,==•=•=~=~~ =-~·=-=c=•·-==o·==~-~-=~~-ct.' c·. . 
:' 
,I 
li 
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I' 
:I II 
II 
occurs. 
These hypotheses and othemwhich have been proposed to 
explain this fact are rather unsatisfactory and this dis-
crepancy might well be considered the weak or missing link 
in the otherwise strong chain of evidence in support of 
Levine'~ theory of pathogenesis. However, work reported 
within the past few months may provide the answer to this 
nmissing link". 
1 
Diamond and Abelson ( 43) announced a nev.r slide agglutint 
ation test for the demonstration of anti-Rh agglutinins. 
Using this new method they detected the presence of it anti-Rh!i 
ii 
[I in 79 out of 80 mothers of infants with hemolytic disease of ' 
11 the newborn. Wiener (44) was at first unable to duplicate 
il 
'I 
II 
!I I, 
I 
I 
iJ II 
I[ 
!1 
!I 
" il 
il 
r 
Diamond and Abelson's results~ and undertook an analysis of 
the mechanism of the reaction. He found that best results 
were obtained in this test {and in his modification of it) 
by making all dilutions with plasma or serum, thus 
preventing dilution by saline of a colloidal serum protein, 
"conglutinin", which he found caused massive clumping of 
red cells after the specific antigen-antibody reaction had 
taken place. He postulates that the reason that reactions 
in hemolytic disease of the newborn are sometimes delayed 
for hours or days postpartum is that nconglutinin" does not 
'i develop in these infants until shortly before or after 
l
i I birth. This hypothesis is now being tested by studies on 
~ l1 fetal and infantile conglutinin. 
~=~-----..=~~---~~=~-~- - ------------ --- ---=~=~-==--c-=-= 
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Darrow (45) agrees on the importance of the Rh factor 
)j in the causation of erythroblastosis fetalis, but she 
11 believes that "passive isosensi tization" explains the 
t! 
!I findings better than simple iso-immunization. She 
that the primary concern is not the destruction of red cells li 
li 
:i but the damage to liver and lungs, which, according to her, 
1
! 
are the "shock organs". 
The factors influencing the severity of hemolytic 
disease of the newborn are the age of the fetus when 
ii 
i! 
I; 
:i anti-Rh antibodies begin to act on it, the duration of 
i! ,, 
il exposure of the fetus to antibody action, and the strength 
1/ 
I. II I! 
of the anti-Rh titer {30). When antibodies in high titer 
have been acting for a long period of ttme, the clinical 
i! 
!J picture of hydrops fetalis results. When the iso-
li 
'I 
II ~~ I. 
:I !: 
I< 
'i 
!i 
II 
It 
II 
II 
/I 
I 
I 
!1 
immunization has been mild and the exposure to antibodies 
has been short, the picture of congenital anemia is seen. 
Icterus gravis is the clinical type which is intermediate 
in severity between the above two (33). 
It has been suggested {46) that when iso-agglutinins 
.s 
reach a peak of activity early in pregnancy, spontaneou; 
abortion oc·curs as a result of the action of the agglutinins!: 
I! 
on the fetus. Walsh (47) presents a suggestive case histo~ 
I' 
The re sul ts /i 
(direct copy~! 
•' i ,, 
.I 
The mother was Rh-, the father homozygous Rh+. 
of six consecutive pregnancies were as follows 
1. Normal child 
2. 
1934: 
1935: Child slightly jaundiced at birth. i' II 
... --......... === ····~ik· 
I 
,[ ;; 
16. 
3. 1937: Child intensely jaundiced, died in 
spite or transfUsion therapy. 
4. 1940: Hydrops foetalis. 
5. 1942: Miscarriage at six months of pregnancy. 
6. 1944: Miscarriage at three months or 
pregnancy. 
Others, however, don't believe that the Rh factor is 
important in early spontaneous abortions (21,48). 
There may be some sex-linked factor operative in the 
incidence and severity of hemolytic disease of the newborn. 
Potter (36) reported that one of the predisposing factors 
in the production of the disease is a large proportion of 
male children in preceding pregnancies, particularly in the :· 
last one. Halperin et al (49} reported that the disease 
is three times as common in male as in female infants and 
that the ratio of fatal cases is five males to every female. : 
1'7. 
CLINICAL PICTURE 
~- _.._,__~-- --
-------------~-tr-------- --- · --------
Clinically, hemolytic disease of the newborn runs a 
fairly typica~ course. For the sake of convenience, three 
clinical types are described according to their severity; 
but there are frequently intermediate cases with over-
lapping of signs. 
The most severt manifestation of the disease is the type: 
!: 
known as hydrops fetalis or universal edema of the fetus. 
Fortunately, this occurs uncommonly (50). In this type 
the disease process reaches its peak in utero. Frequently 
the infant is born a month or more prematu~ely ('7, 24) and 
is either stillborn or it dies shortly after birth. 
Respiration is initiated with difficulty, if at all, and is 
then gasping and irregular (6). The skin, which may be 
covered by a thick, yellow vernix caseosa, is characterized 
by a waxy pallor. Jaundice is absent or slight. The edema, 
which is present at birth or develops on the first day, may 
be localized to the extremities, but there is frequently 
marked, generalized pitting edema with hydrothorax and 
ascites. The latter, together with a markedly enlarged 
liver and spleen, gives rise to a distended abdomen which 
may be large enough·c to cause dystocia. The heart is 
enlarged and a murmur may be heard over the precordium 
(6, '7). Due to the edema, the neck and extremities look 
short and there is a suggestion of a mongoloid facies. !' 
the thoracic and abdominal enlargement, 
-=-=co-.-=c.-·c.c .. ~"~·-.c c.-cccc~~=~c-7-- -co~-- -, -" -_-_ ~~-~~---- _ 
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may give rise to a Buddha-like habitus (24). 
Icterus gravis neonatorum is the intermediate type of 
hemolytic disease of the newborn in point of severity; it 
is the most frequent in incidence {6, 50). 
According to Abt (2) most of the infants are "strong, 
robust and mature at birth", but signs of the disease 
appear rapidly. The infant is covered by a golden-yellow 
vernix at birth and may be slightly jaundiced (6). Accord-
ing to Diamond, Blackfan and Baty both icterus and pallor ar+, 
:I ,, 
usually visible in the skin and mucous membranes at birth. !! 
The jaundice increases rapidly in intensity during the first :I 
i, I 
1\ 
I 
i! 
il 
II 
II· i! 
48 hours, masking the pallor which is an expression of the 
severe anemia. The liver and spleen are readily palpable 
and may increase in size concurrently with the increase in 
jaundice and anemia (?). They become listless and weak, 
i! have a feeble cry, and they nurse poorly (50, 51). Darrow 
ii 
I' (12} noted that they show either somnolence, listlessness, 
il 
i! and flaccidity or muscular twitchings, opisthotonos, and 
il 
li I! occasionally, convulsions. Petechial hemorrhages, 
II 
li 
11 
ecchymoses, bleeding from the umbilicus, hematemesis, 
li 
II hematuria, and melena are not uncommon. Moderate edema of 
il 
II the extremities, eyelids, or scrotum sometimes occurs. 
i[ 
ii There may be respiratory difficulty with cyanosis, labored, 
it 
il grunting respiration, and a whining cry {6, 12). The 
li cyanosis may be intermittent at first and then become 
n 
"' ~ersistent. Terminally, there is vomiting, dyspnea, 
7--~- .c~~~~-~~----~~~=~~c-c~~~~··~~-c~==-~~~~-~-==•=-----•~~-~-- ,, __ -_, _,c~•-- ___ ,, _ __ -----
.; 
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of blood-stained fluid (52), leading 
In fatal cases, death may occur 
within 24 or 48 hours, or it may be delayed for days or 
weeks (12). Between the sixth and twelfth days, the stools 
may become acholic and the urine bile tinged. These signs 
of an obstructive jaundice persist from a few days to weeks 
(53). 
Congenital anemia of the newborn is the most benign 
among the three types. It shows a definite tendency to 
spontaneous recovery. The only constant clinical finding 
is pallor. This is associated with an anemia of greater 
or lesser degree appearing some time in the first two weeks 
of life (54). Moderate jaundice may be present for a few 
days; its disappearance may unmask the marked pallor for 
the first time. There is usually hepatosplenomegaly (7,52). 
The infant may be vigorous and cry lustily (54,55) or it may: 
be weak and listless and nurse poorly (52). In non-fatal 
cases of icterus gravis or of congenital anemia, gradual 
return to normal occurs over a period of several weeks. 
Javert (24, 5~) in his classification of the types of 
erythroblastosis fetalis, introduced a new type which he 
termed "hemorrhagic diathesis", which was characterized by 
bleeding from the umbilical cord, melena, hematemesis, and 
e. 
petechiaJ of the skin. In support of his contention that 
this type is deserving of a separate place in the 
classification,he stated, "ln none of these was there 
------ - --------------·--·- ---- --·· 
;; 
!i 
=n====-*I!=== 
1! jaundice, or hydrops, to overshadow the hemorrhagic 
!f 
I' diathesis." But, as previously noted above, the srune 
"hemorrhagic diathesis'' has been reported in cases. or 
icterus gravis (6). It would~ therefore, appear that 
Ja.vert•s cases of "hemorrhagic diathesis" were just cases 
of the simple anemic type of hemolytic disease of the 
newborn in which the hemorrhagic tendency was the most ii !I 
prominent feature. This concept is lent support 
mortality statistics (56): 
by Javert' ~I 
li 
;[ 
Hydrops fetalis 
Icterus gravis 
Congenital anemia 
Hemorrhagic diathesis 
Fetal Mortality 
100% 
45 
25 
25 
[I 
The addition of rrhemorrhagic diathesis", as a separate 11 !! [; 
manifestation, to the classification of hemolytic disease of !I 
ii the newborn is, therefore, unjustifiable. i1 
II 
li 
i! 
:: 
li 
I 
21. 
PATHOLOGY 
The fundamental pathological processes in hemolytic 
disease of the newborn are excess hemolysis and hepatic 
il dysfunction (12). 
!I 
ii 
According to Blackfan, Diamond, and 
II 
II 
il !i 
'I 
l1 
II 
il 
!I 
ii 
'I 
:i 
il 
il li 
ii 
!I 
il 
!I 
Leister (53), "the symptoms and signs may be explained on :i 
II i! 
the basis of excessive hemolysis, abnormal activity of blood i! 
production, and interference with the normal .function of the i' 
organs that are the site of extra-medullary hematopoiesis 
and hemosiderin deposits, chiefly the liver and the spleen." 
The general pathological picture is as follows (6,7,12,57): 
The tissues and organs are pale. 
Hematopoiesis is seen in the liver and spleen 
and inconstantly in the kidneys, adrenal glands, 
pancreas, lymph nodes, thyroid, gonads, prostate, 
thymus, pituitary gland, and the placenta. 
!I 
li 
i: 
li 
II 
I ,I 
Hemosiderosis is found in the liver, both in the hepatiql 
II 
parenchymal cells and in the Kuppfer cells, in the phagocyte~! 
1: 
of the spleen, and in the convoluted tubules of the kidney. !i 
The liver is congested and enlarged to 2 or 3 times its ~~ 
I! 
normal size. Microscopically, there are diffuse or focal 
hematopoiesis, dilatation of the bile ducts, and bile I! II 
i! 
thrombi. The damage to the hepatic cells ranges from cloudy I! 
swelling and atrophy to necrosis, and the cells contain bile !i 
I! li and iron pigment. The Kuppfer cells contain phagocytosed i! 
1
1 red cells and iron pigment. il 
II /! ] The spleen also is congested and it is enlarged 4 to 8 11 
·o.c.~~c~ol==·--~-==-· -~c·c cc:_c-~··o--~--=-c.~o=c~-c·c~----~----=-=~===~c·.- r·-o·cc·--
11 
!! 
n_c- ~~-=-==r . 
1 
ii times its normal size. 
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Microscopically, hematopoiesis is 
II ii prominent, the Malpighian corpuscles are obscured, and there :i 
I '• lj ,, 
il is hemosiderosis and marked phagocytosis of red cells. 
I! 
!i 
if 
:, 
I! 
!i 
The heart is moderately dilated and hypertrophied. 
The lungs show edema of the alveolar walls with 
il hemorrhage or hematopoiesis. 
II 
i! 
il 
II 
I' 
,I 
il 
The bone marrow is hyperplastic. 
Petechial or larger hemorrhages may be seen in various 
!i 
I! organs, such as the lungs, brain, skin, and umbilicus, and 
II 
1, from mucosal and serosal surfaces. 
'I II 
II ,, In hydrops cases (5?) there are, in addition to the 
II 
l/ general pathological picture above, generalized edema, 
r 
. I 
!I 
ascites, hydrothorax, and hydropericardium • !i The placenta is il 
il II 
II 
II that the fetal- !1 
I' 
placental ratio may reach 3:1 instead of the normal 6:1 (24)1: 
enlarged to 2 or 3 times the normal size, so 
II 
The placenta, in hydrops, is thick, spongy, friable, and a 
pale grayish-pink in color. The villi are edematous and 
hyPerplastic, and the vessels contain nucleated red blood 
cells. The bones may show abnormal ossification with an 
:: 
•: 
abnormally large number of calcified cartilaginous trabecula~. 
There may be an increase in the size and number of the 
11 islets of Langerhans in the pancreas. Gilmour (5?) 
1: 
ii described a previously unreported microscopic finding which 
!! il he considered to be the most nearly constant pathological 
)/ finding and one which was pathognomonic of hydrops fetalis. 
I"'\ ~~0~~~::;;•~ :on•i~t-ad o: a w:~":-a':':" o~_lipoid vacuolization of the 
fi 
,I 
li 
l! 
i 
,I 
==~+================ 
il 
23. 
11 inner part of the adrenal cortex. 
II ,. 
il In icterus gravis cases there is jaundice of the skin, il !: 
!I 
1
: mucous membranes, and of the tissues in general, and there 
!I 
II 
ll 
II 
:1 
II 
!I 
il q 
il 
I' II 
,I 
li 
:1 
!i ,, 
:i !, 
il 
are small amounts of bile-tinged fluid in the serous 
cavities ( 12). There may be a diffuse yellow discoloration 
of the brain or there may be localized Kernicterus. 
Kernicterus is a necrosis and yellow discoloration of 
nuclear masses in the Central Nervous System. It is 
practically pathognomonic of hemolytic disease of the 
newborn (58) • It most commonly affects the caudate, 
lenticular, subthalamic, and thalamic nuclei, the mamillary 
!I 
i[ bodies and the hippocampus; and it has been reported in the 
!1 dentate nuclei, nuclei of the cranial nerves, the olives, 
II 
J! parts of the cerebellar cortex, and the anterior and q 
'I !I i! posterior horns of the spinal cord (59). 
I' 
,I The pathology in Kernicterus consists of demyeliniza-I! 
il 
11 tion, degeneration, and necrosis, probably on an ischemic 
1
1! basis, with secondary pigmentation (60). The location of 
I,·  the lesions may be explained by the fact that the basal 
il 
11 ganglia, especially the corpus striatum and the hippocampus, 
II 
!I have a relatively poor blood supply and are among the first 
I structures injured by any condition of anoxemia (61). 
il !, 
[I 
,I 
c ..• ··~~~· ~ 
II 
i! 
!i 
:: 
n ~- --t .. f l I 
II 
I! 
ii 
LABORATORY FINDINGS 
Studies made on umbilical cord blood in cases of 
il II I! hemolytic disease of the newborn reveal a typical 
il ll hematologic picture. 
d 
II hemoglobin value relatively less depressed than the red 
il 
I! 
There is a moderate anemia, with the 
cell count so that the color index is more than 1. There li 
li 
" 
IJ 
!I I 
!I 
'I 
II 
is a leukocytosis and an abnormally high number of nucleated j[ 
I! 
!i 
red blood cells. The normal premature or full-term infant t! 
11 
!I has between 200 and 2,000 nucleated red cells per cubic 
il 
II , millimeter; in this disease 10,000 to 100,000 or more may 
fi 
il ,, 
:• i! 
1: 1
1
1 be found (53) • Javert (56) presents the following average ,, I' 
I! 
.I 
!! 
ll 
'I II 
,I 
II 
I! 
ll 
II ii 
II 
II 
figures for cord blood: 
5 Hydrops cases 
6 Icterus eases 
4 Anemia cases 
R.c.c. 
1.51 
3.38 
3.5 
Hg (Gm.) 
5.5 13.1 
12.0 
w .c.c. 
54.3 
38.4 
29.8 
N.R.C. 
43.5 
17.7 
13.0 
R.C.C.=- red cell count in millions; w.c.c.= white cell 
in thousands; N.R.c~~nucleated red cells in thousands 
cubic millimeter; C.I.~color index. 
ii 
C.I~ 
1.311 
1.41! 
1 4 '1 
• II 
count ij 
li per I' 
ll 
II 
'I 
I' 
" There are large numbers of reticulocytes, cells with 
,I
II nuclear fragments, normoblasts and erythroblasts, and, 
I' li occasionally, megaloblasts (29,53). The red cells may show 
11 anisocytosis, poikilocytosis, and polychromatophilia (62). 
,, 
II 
,J Except for hydrops cases, in which initial red cell counts 
IJ as low as 500,000 per 
II 
cubic millimeter have been reported, !1 
'I !, 
il the anemia may remain slight for the first 12 hours; then itli 
11 gets worse with a rapid fall in the erythrocyte count -
sometimes it may decrease by as much as a million per cubic 
-- ---=-=.. - -::::-=----=-::-~-~- _:--_--;;-:;---:::_-- =---=----=-----=----- ~-=-~-,;_----=::: =-==.=---:::-::......_.~--=--
!1 
li 
•! 
!! 
II 
li 
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li millimeter per dav. 
il " 
The anemia may be profound by the third 
By this time the nucleated red cells [i or fourth day (53) • 
II are usually greatly decreased in number and may disappear 
!I 
II by the end of a week or 10 days (24). The macrocytosis 
II 
tl ~ persists, however. 
lr 
The fragility of red cells in hypotonic 
I[ saline solutions is normal or slightly decreased (53). 
j) There is a leukocytosis with many immature cells of all 
kinds, including myelooytes, myeloblasts, and young 
lymphooyt~and monooytes. The white cells gradually become 
more mature in character (7). There may be an eosinophilia 
or monocytosis or both (12). 
Platelets may be decreased in numbers in the first few 
days with an increased bleeding time. There are a hypo-
proteinemia and hypoprothrombinemia, most marked in cases 
of hydrops. The icterus index is above normal and rises in 
the first week. This is most marked in oases of icterus 
gravis in which the icteric index commonly reaches 100 and 
I, 
II in which icteric indices as high as 600 and 700 have been 
il 
II 
i[ 
il 
il 
!I 
I 
I 
'I 
II 
li 
reported (63). The van den Bergh reaction is biphasic 
indicating that the jaundice in this disease is not purely 
hemolytic in character. In icterus gravis cases there are 
increased urobilin, bilirubin and bile salts in the urine 
(12). 
Blood cultures, tuberculin tests, and Wassermann 
26. 
DIAGNOSIS 
No single feature is pathognomonic of hemolytic disease l: 
of the newborn. Anemia is the most common finding, but 
perhaps the most significant diagnostic criterion is 
splenomegaly. If the spleen can be palpated 2 centimeters 
below the costal margin, or if the spleen weighs more than 
25 grrums at post-mortem, the differential diagnosis lies 
only between hemolytic disease and congenital lues (23). 
However, the diagnosis must be made on the basis of a' 
complex of signs, not on a single feature. 
Diamond, Blackfan, and Baty (7) proposed a set of 
criteria for the clinical and pathological diagnosis of the 
different manifestations of erythroblasto~is fetalis. These 
are as follows: 
·' ;1 
Hydrops fetalis 
general edema 
splenomegaly 
hepatomegaly 
pallor 
icterus 
extra-medullary 
(in the 
hematopoiesis) 
tissues 1: 
II 
Icterus gravis neonatorum 
familial incidence 
early and severe jaundice 
anemia 
large numbers of nucleated red cells 
splenomegaly 
hepatomegaly 
extra-medullary hematopoiesis 
Congenital anemia of the newborn 
severe pallor and anemia shortly after birth 
early presence of large numbers of nucleated 
red cells 
splenomegai'1 
..... ~~E~t~=~iiJ~~ ~mat9-R9~~s~s c 
,. 
q 
27. 
To the above criteria may now be added serological 
findings showing an Rh+ father and fetus and an Rh- mother 
(17) and the demonstration in the mother's serum of iso-
antibodies (43). 
The prepartum diagnosis of hemolytic disease of the li ·, 
1 li 
11 newborn is of importance in the management of the delivery I! 
I' 'I 
!I and for institution of prompt treatment to the infant. When li 
!! '!!, ii 
11 there is an obstetrical history of previous infants suffer- 11 
il ing from the disease, the finding of excessive uterine /i 
tl il 
li :f !I enlargement for the duration of pregnancy is indication of 11 
II 
1
1 
:1 the possibli ty of hydrops fetalis. The uterine enlargement ~~ 
i 
I 
II 
II 
II 
II 
II 
II i! 
I 
i 
I 
was for.merly ascribed to hydramnios, but Javert (24) has 
shown that it is actually due to the excessive size of the 
fetus and placenta. Hellman and Irving (64) reported that 
the diagnosis of hydrops could be made in utera by means of 
ii p 
the X-ray. Edema shows up as a thickening and increased 
density of the soft parts. In the scalp this may show up as !i 
a distinct corona around the skull. ·Moreover, the thoracic II 
!I 
'I 
and abdominal distention and the relatively short, edematous(! 
neck and extremities give rise to a diagnostic intra-uterine il 
II 
Buddha-like habitus ( 24) • However, the X-ray findings are II 
ij 
not always typical, and since hydrops is relatively i: I I' 
I i fr t d the ty e which is least amenable to treatment~ 
11 
n equen an P I! 
/1 the use of the X-ray is of distinctly limited value. Other 
1
:: 
il I 
t(" ~~~J11 i'c· :;;~::v:o::~t:;::;:~:h:_i_:~::o:;• P~;:;::;y~:::::l:s to tic ~ .. r I! 
II 
I! 
!! 
H :' 
I! ~-~---c===r -===~-~~~ 
11 infants, are toxemia of pregnancy, a systolic bruit of the 
28. :1 ·'·=-.-~-~''='~'-='-~~-~-fi-e=·==~~====-~ 
/I fetal heart, and fetal distress before and during delivery 
(24). 
A more practical and accurate method of making the 
il diagnosis is the demonstration in the pregnant Rh- mother's 1! 
'~~~ serum of anti-Rh antibodies. The presence of iso- agglutini[;s li in the last trimester indicates potential danger to the 
!I 
d II 
lj 
II 
I 
II 
II 
II 
II 
!I 
II 
II 
II 
I' 
,I 
II jl 
II 
II 
II 
il 
II 
II 
fetus. A rising titer makes it increasingly probable that 
the infant will suffer from the disease. A sudden fall in 
titer makes it almost certain, that the fetus will be 
seriously affected; and if the blocking antibody first 
appears as the agglutinin titer falls, it usually indicates 
a fatal outcome for the fetus (65). 
De Lange and Arntzenius (66) first called attention to 
the dark yellow amniotic fluid and the yellow vernix caseosa 11 
which are often seen during delivery and which should lead 11 j! 
to an early diagnosis. This has been confirmed by subsequenJ 
observers (6,7). 
The differential diagnosis of hemolytic disease of the 
newborn includes congenital syphilis, ante or post-natal 
infection, congenital malformations of the liver or biliary 
system or of the heart, spontaneous or traumatic hemorrhage,' 
various blood dyscrasias, and physiological jaundice of the 
newborn (53). 
Congenital lues can produce all of the manifestations 
reaction and on the Rh and anti-Rh determinations. 
Severe infections can produce a blood picture similar 
to that seen in this disease, but fever, diarrhea, and signs 
of localization, and sometimes a positive blood culture 
indicate the infectious nature of the disease (7). 
Hemorrhagic disease of the newborn and traumatic 
hemorrhage may simulate the hemorrhagic manifestations of 
erythroblastosis fetalis, but there is usually no familial 
q incidence, no reduction in the number of platelets, and no 
I' :I 
II 
II 
I: 
II )I 
II 
" tl ii 
II 
il 
'i [, 
p 
severe icterus, splenomegaly, or hepatomegaly (7). 
The obstructive component of the jaundice in icterus 
gravis may so overshadow the other manifestations of the 
disease as to lead to a diagnosis of malformation of the 
biliary system. 
Aries (67) reports such a case in which the stools I ~ 
II 
rl 
II 
1: 
became progressively acholic until they were clay colored on Ji 
il 
!l 
II 
1: 
!i 
II 
I' II 
ii 
:I 
il 
I' 
if I; 
I! 
the eighth day, while the urine gave a strong reaction for 
bile, but contained no urobilin. Exploratory laporotomy 
for supposed atresia of the bile ducts revealed a normal 
biliary system. The infant subsequently recovered and was 
shown to be Rh+, with an Rh~ father and an Rh- mother. 
Physiologic jaundice of the newborn is a mild degree of 
jaundice which usually doesn't appear until the third day of 
,
1 
life and is usually gone by the end of a week. It is not 
il 
~ 11 associated with abnormal numbers of circulating 
~~ ~· ~ ~-CC7~= =~=~~~~=7=-~~- · ,-~_,_=~~~ -- ~~ ~~ _c- ~- c~ --~, c~.~ ~_, c_c c·~ = ~=,-~~cc_~~=c~·~c--cc~cc ~ ~-·c=c.c·~~-~ ~ __ ~ ~-'~ _ ~ ~ ~~ 
1! ,, 
i! 
nucleated 
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J! 
red blood cells, splenomegaly, or hepatomegaly; and the van ii 
1! 
I' 
den Bergh test is positive only for the indirect reaction, 
unlike the biphasic reaction in hemolytic disease of the 
newborn. 
In all doubtful cases, the determination of the Rh 
blood types of infant and mother, and the demonstration of 
iso-antibodies in the mother's serum is of the greatest 
diagnostic significance. 
Davidsohn {30) has presented an excellent outline of 
the differential diagnosis of erythroblastosis fetalis 
(fig. 2). 
Fi~. 2. Differential Dis 
Fetal 
Erythroblastosis 
Familial incidence -t-+ 
-st··Ienom:a·· al · ~- ...,. -r p g y -·--·. ········· . . . ... 
Hepatomegaly Aheniia · ··· · -r+ ++ 
Leukocytosis ... ···--··- T. + 
Leukemoid blood picture -t ..,. 
-Erytnrobiastem'!-~~- ----·· -----
lc :ce·rus-gfay!s t ----·-- ++ ++-
- !Jig? icterus_ index__ +r 
Indirect Van den 
Bergh reaction 
-]!:[phasic Van den 
Bergh reaction 
Bile in ·urTne -- -~~··· ·· 
·UrObilin in uririe 
-p --···· ··········· .. 
urpura .. . _ . 
-~g~~: ;·gi~~~1;l ______ -···· ·····- ... 
- Erilarged plac-eni[~--¥ 
Extramendullary 
+-r 
++-
+j-
±.+-
++-
...,.. 
-+. 
-.-r 
hematopoiesis {at term) -r-t-
Hepatic biliary stasis ++-
Hepatic damage ···· · + + 
Hemosiderosis + + 
Positive tests for syphilis -
Father Rh+,mother.Rh-, 
baby Rh+- -t-1- iN 
Anti-Rh agglutinins 
in mother 1 s bloo.d +r 
. ! 
<;o] 
Congenital 
Syphilis 
++-
.. -+ -t ... 
++ 
-t-+ 
r+ 
-rr 
-r-r 
++ 
-rr-
~...,.. 
-t-t-
+-1-
++ 
-r+ .. 
+ 
+ 
-r+-
+-J-
++ 
...,_..,.. 
r+ 
-t+ 
Antenatal 
Infection 
r···" 
+ 
++ 
-t-+ 
"1"-t-
....,.. 
+-t-
-T 
+ 
-t-
-r 
++ 
T--r 
-t-
+ 
..,.. 
+ 
-ive Born Infants 
Hemorrhagic 
. Postnatal disease of 
Infection Newborn 
-t-
+ 
+-t 
+ 
..,.......,.. 
+.+ 
, .. 
Congenital Congenital ~ 
Malformations Malformation Icterus 
of Bile Ducts of Heart Neonatorum 
++ 
...,.....,. 
..,....,... 
+-r 
-t-+ 
~...,.. 
++ 
-T 
-t-
+ 
..,.. 
..,.. 
-t- + 
...,.... 
+ 
-r 
...,..... ...,... 
--* Erythroblastemia is used to indicate presence of innnature nucrl;teated red blood cells in circulation in excess of 1,000 per 
cuoic millimeter 
I 
_t_ Icterus gravi~ is used to mean severe jflundice pi'esent at .. birl1:;h o.X' within 48 hQ1J.rl3 af.ter bi:rth. £tpd ].g_~t:lPg_p_Ery()nd :the first 
week of life. ( 
:#= ;.v~:rage weight of normal placenta is about one seventh .of' bodrY- w:e_igl:l_t,. 
' . + !.f<tnc::licates frequent occurrence ;-t-, occasional occurrence;-, 
~ 
\ 
-unc ;Qmmon 
i 
occu.rrence;-:t.nd:Lc~tes ~bsence as a rule. 
(Davidshhn I.,JAMA 127:633-8,1945) 
31. 
PROGNOSIS 
The outlook in hemolytic disease of the newborn has 
been very poor. In hydrops cases, the mortality is lOO%; 
death usually occurs within 36 hours, the longest reported 
survival being ll days in a case of Javertts (24). In 
icterus gravis cases he reported a 54% mortality even with ,, 
it 
u !I blood transfusion therapy. With modern therapeutic regimens~ 
il il 
1! including the use of Rh- blood for transfusion, the mortali~ 
II in icterus cases has been cut to 25% (52) or even lower (68) ~ 
q " !i !! il In the simple anemia cases, the usual tendency to spontane- ;1 
j, il 
il 
II 
ll 
II 
I 
ous recovery is greatly hastened by adequate therapy (52). 
If edema is absent and jaundice and anemia develop 
slowly, the prognosis is good, especially if vigorous 
treatment is instituted early {53). Prognosis can also be 
based on the nucleated red cell count. If it is highest 
the first or second day, then falls off rapidly, the 
prognosis is good; if the number remains high or increases, 
the prognosis is poor {69). 
The prognosis for future pregnancies once parents have 1 
had a child suffering from hemolytic disease of the newborn 
depends on whether the father is homozygous or heterozygous 
Rh~. If he is heterozygous, he has a 50% chance of siring 
an Rh-, normal infant. If he is homozygous, all subsequent 
pregnancies resulting from the mating will give rise to an 
jl Rh+ fetus which will be affected by the disease and, 
l= ero ~~~~1'1," ~0 _a sev~rel:~ d~gl"!~·=-~,l: t~=lll~x:e .. jaundice or even 
!I 
I II 
) 
32. 
hydrops (21). 
On the basis of studies with an St serum (similar to 
the anti-Hr of Levine) which was able partially to ,i 
j; 
differentiate between homozygous and heterozygous Hh+ bloods,!! 
1: 
Race and Taylor (70,71) have suggested that a majority of 
fathers of infants suffering from the disease are 
li 
ii 
homozygous. If this should 
I[ 
prove to be true, the prognosis ii 
I! 
II 
!i for future pregnancies must be altered downward from the 50% li 
r 
11 chance for a normal child reported by Javert (24). Support 
il 
1: for this idea is seen in Potter's statistics (25). Of the 
II 
!; 50 women in her series of mothers who gave birth to 
li 
II erythroblastotic infants, 22 subsequently gave birth to 37 
ii 
II infants, none of whom escaped the disease. 
11 The sequelae of hemolytic disease of the newborn seem 
II I'. 
11 to· be confined primarily to the icterus gravis type. 
1
11'1 Greenish discoloration of the deciduous teeth has been 
II 
II reported (21,63), and juvenile cirrhosis of the liver has 
II occurred following icterus gravis (24,62). 
I' ,I The most important sequela, however, is Kernicterus. 
II li J avert ( 24) found it in 45% of his fat a 1 cases of icterus 
il II gravis but in none of the other types of erythroblastosis. 
II 
II Docter ( 60) reported 20 cases of icterus gravis. Of these, 
II 
11 12 or 55% showed clinical or pathological evidence of 
d ii ii Kernicterus. Out of 13 who survived the neonatal period 5 
If or 38% showed neurological sequelae. These consist of 
II 
M ·~ . ~I var:In! ~ c ~~bi.n~ ti ons~ atld ":.grees of extra-pyramidal 
li 
il 
r/ 
" ~~~--~ ======= 
' l ii 
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il spasticity, choreiform and athetoid movements, emotional 
fi 
ii irritability, and mental retardation {21, '72). 
Yannet and Lieberman (58) maintain that there is no fl il 
ii il correlation between the severity of the neonatal symptoms 
!I ii and the cerebral damage. They claim that some cases of 
il 
fl "undifferentiated" mental deficiency are sequelae of 
!I 
I[ hemolytic disease of the newborn with neonatal symptoms so 
II 
l1 mild as to have gone unrecognized. They base this concept 
li 
! 
on the finding of an increased incidence of Rh incompatibil-
ity in this group as compared with a control group afflicted 
with mental deficiency of known origin. This hypothesis 
will have to be confir.med. 
~-+ 
II 
34. 
TREATMENT 
il ii The principal form of therapy for hemolytic disease of 
Ji the newborn is the intravenous transfusion of whole blood. 
il Most workers in the field recommend the early use of 
:[ 
ti II compatible Rh- blood (21,35,36,42,68). Darrow (45), on the 
II 
l'1 other hand, uses Rhf blood by preference because of its 
II 
lr sparing action on the infant's cells, its greater 
!J desensitizing effect, and its availability from the family. 
tl 
11 However, the bulk of the evidence seems to support the use 
il 
1
1 
of Rh- blood. 
I 
·I 
Gimson (68) reported two series of cases of 
erythroblastosis fetalis. The first series of 17 consecu-
tive cases were treated between 1935 and 1941. The second 
series of 18 consecutive cases of comparable severity 
(16 icterus, 2 anemia) were treated with Rh- blood. 
In the first series, 6 died and 11 recovered. In some 
!
I cases up to 6 transfusions were required, and an analysis of 
the blood picture showed there had been little improvement 
,, 
11 following transfusion. In more than half the cases, there 
,. 
1
1 were transfusion reactions characterized by temperature 
11 elevation, increased jaundice, and increase in the size of 
l1 the spleen and liver. 
:! 
'I I· II In the second series, all 18 recovered. 8 required 
II 
Jl only one transfusion; the ... 'other 10 required only 2 trans- ,, li 
!! fusions of Rh- blood. There was only one reaction, and 
~ i followed a transfusion of mixed Rh- and Rhf blood. 
, '" ··,•co•~~~,=~"C=,cl•_,_=~=•=·=" ,==·"-''"""-,"=-- - "'----- ,,".~,,-=~-=~ •=~~-~-'"" -'~" ,, 
,I 
li 
!I 
ii 
li 
this i! 
il 
II 
i II 
il 
:j· _" 
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Mollison ('73), by a technique of differential 
agglutination, studied the survival time of transfused Rh-
and Rh~ blood in infants with hemolytic disease of the 
newborn. In 8 out of 9 cases, transfused Rh~ cells were 
eliminated within 10 days of transfusion. In 20 out of 21 
cases, Rh- blood survived for at least 80 days, which is 
comparable to the survival of transfused blood in normal 
babies and adults. He suggested that massive Rh- trans-
fusions temporarily depress hematopoiesis in the infant, 
thus accounting for the rapid decrease in jaundice which 
occurs in some cases. 
!! 
!: 
Transfusion of Rh- blood should b,.e given as soon as the /i 
I! q 
diagnosis is suspected. If the diagnosis is made prepartum, I! 
il 
a prophylactic Rh- blood transfusion should be given into il 
!, 
!j 
the umbilical vein at birth (35,42,'74). Wiener and Wexler 
recommend the transfusion of a total of 150 cc. of Rh- blood!: 
,I 
in two daily doses. If, as sometimes happens, all the 
infant's cells are destroyed by the hemolytic process, for 
about a month the infant lives only on the donor•s cells 
i ~ 
'· il ,, 
and has his blood group. Gradually, the donor's cells are 
replaced, and the infant's true blood type appears. In one 
of their cases, the mother's blood was AB Rh- and contained 
anti-Rh. Several days after transfusion, the infant• s blood/1 
I! 
was 0 Rh-. Subsequently, the infant's blood was shown to be;[ 
A Rh~ (35). Brown and Levine ('75) reported a similar case. 1/ 
li Leonard (69) uses plasma infusions to combat the li 
-~ -=~-~=-"~·== == ~ ~=-==-·=- ~.~,~~=~~,.~~---====-~~-==~=-~~=~=-=~-~~==~~- ~~ ~~-
li 
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' - il hemorrhagic tendency and transfuses whole blood only when 
it 
II the hemoglobin value falls to 11 grams per 100 cubic 
Darrow (45) recommends immediate transfusion 11 centimeters. 
II il of 10 - 15 cc. of blood per pound of body weight, repeated 
I il in 12 to 24 hours if edema appears, if the anemia is severe,· tl· 
i! 
,
11
1,[
1 if a hemorrhagic tendency manifests itself, or if the baby 
looks "toxic". Gimson (68) reconnnends transfusion of 
il 
1
11 
!I II 
II 
ii 
I. 
i 
[! 
II 
I 
li 
!I 
enough Rh- blood to bring the hemoglobin value to normal. 
He uses the following formula to determine the amount of 
blood necessary: 
% rise of Hb required 
100 X 
blood volume (40 cc. per lb.) 
Blood for transfusion should be cross-matched v~th the 
mother's blood (73) since, for some time after birth, fetal 
blood contains no agglutinins capable of agglutinating 
maternal red cells (76). Where testing is impossible, 
Group 0 Rh- blood is suitable in the great majority of 
cases. Maternal blood cells washed free of plasma and 
resuspended in normal saline or in compatible plasma are 
always suitable for transfusion (37). 
Darrow (45) recommends the following adjuvant therapy: 
Oxygen should be supplied continuously at the rate of 
3 or 4 liters per minute until nucleated red cells are gone 
from the circulation; it may then be given intermittently 
until the jaundice subsides in order to increase hepatic 
efficiency. 
__ C~~l.~~~S_}~! 80 __ ~~ lOg~=~~c~40-~~!-5t g_~ll~()Se in saline daily 
\ 
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li should be given as long as the jaundice persists. 
I! 
II 
II 
Five to ten cc. of 10% calcium gluconate should be 
II given at the time of transfusions to combat the hemorrhagic 
d 
II tendency. Other workers have recommended the administration 
il of vitamin K or transfusion from vitamin K-fortified donors 
i' il 
il 
·I 
li 
II 
II 
ii II 
II 
!I 
il i! 
I h 
li 
II 
II 
II 
li II I, 
It 
II 
II 
•I 
I' I 
I[ 
II 
II 
il 
II 
'I II 
II 
for the same purpose (24,69). 
Leonard (69) recommends the use of a high carbohydrate, 
high protein, low fat formula and the oral administration 
of 0.3 gram of choline chloride daily to protect the liver. 
Liver extract and iron therapy are valueless during 
the early stages of the disease, but they may be used with 
benefit during the recovery period (53). 
The mother should not be permitted to nurse the infant, 
since anti-Rh antibodies have been demonstrated in breast 
milk {77). 
A controversy exists. regarding the management of a 
pregnant woman who, in the last trimester, shows a rising 
anti-Rh titer. Some recommend early induction of labor 
at eight or eight and a half months of gestation {21,63). 
Others recommend elective Caesarean Section under local ~ i !. 
'I I 
:I 
anesthesia (65 178). 
/i 
Still another group deny the advisabil- i! 
ii I. 
i! 
II 
!; 
il li 
I' 
II 
II 
!I 
ity or justification for either procedure (21,24,36). 
The rationale of the first group is that early indue-
tion of labor results in the birth of a child with a milder 
form of the disease and a better chance for survival. The 
~ i[ second group have the same rationale and they offer the ,~.~-.~-~~.=~, -'-t~=='='•~-~c,-.,~o' ~~.~~"~~~-~~ ~~'--=~ ,~~=~~=~~~-===~-=~' ~ 
,I 
~: ij 
li 
I 
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' i, 
ii further argument that intrauterine asphyxia is a factor in 
I,, 
[[ the high death rate in this disease; Caesarean section under 
!I local anaesthesia eliminates the asphyxia attendant upon a 
long pelvic delivery. The third group say that the procedur~s 
!i 
are unjustifiable because, at best, they don't alter the 
course of the disease; and they may make matters worse by 
adding the factor of prematurity to an already serious 
condition. The evidence, thus far, is inconclusive, and 
1 judgement on these divergent ideas must be withheld for the 
1/ 
!1 present. 
ii li In any case, when the diagnosis is made prepartum, 
II 
1/ general anesthesia and analgesia should not be used during 
~ Ji delivery (24,78), and preparations should be made in 
advance for transfusion, intubation or tracheotomy, removal 
of thoracic fluid, and administration of oxygen immediately 
upon delivery (36). 
Prevention of hemolytic disease of the newborn is a 
ii il long-range project and can be only partially successful. 
II Artificial insemination of a mother from an Rh- donor is 
II II effective; but this method is applicable in only a limited 
·I 
i 
11 number of cases. 
II 
// Levine (33) showed that once a person is immunized by 
It il the Rh factor, the immunity probably lasts for life. 
!i 
!i Although the an ti-Rh demonstrable in the blood may be 
I· 
1! evanescent, the reticulo-endothelial system apparently 
il 
~ ii remains capable of a rapid response to the Rh antigen, at 
. _____ :::.~_-:_·.;:-::::....=;~~-=-·--=---:---::=_-::--;--_:-_- --;;..:~-;-_-:-::-_ _ -_ -- --~-~~ ::-_::--__ -_··-_ __;::__;;_--::-::___ _ _::::____:__-_:;-:--==·-:-:.:-; __ 
:I 
I' li d 
I' 
,I 
1== t 3=9=·====== 
:1 leas_, for many years, by a mechanism in the nature of an 
anamnestic reaction. In cases of hemolytic disease of the 
il newborn occurring in first pregnancies, a large percentage 
[I 
ii 
II i! ,, 
II 
II 
il 
II 
il 
!I 
II 
II 
' 
il II I, 
I 
I 
of the mothers gave a history of previous transfusions, 
sometimes in early childhood; and, in many of these cases, 
the previous immunization was enough to cause severe 
intrauterine hemolysis and death of the fetus (79). Levine 
recommends, therefore, that "no transfusion be given to 
young women, girls, or even female infants unless tests for 
Rh are carried out." 
I• 
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. ~~ CONCLUSIONS 
q 
II Hemolytic disease of the newborn results from iso-
II 
!I immunization of the mother by a. dominant hereditary factor 
q li in fetal blood with the subsequent hemolysis of fetal red 
if 
ll 
'I 
cells as a. result of reaction \Uth the antibodies thus 
l! 
I! formed. 
,I 
i! II In the majority of cases, the antigen responsible for I! 
jl 
!I the iso-immunization is the Rh factor. 
The disease is characterized by anemia, splenomegaly, !I 
fl 
ii !I hepatomegaly, erythroblastemia., pallor, and jaundice or, 
I 
II 
I occasionally, generalized edema. 
I 
I 
Three clinical types are recognized. These are named 
l
lll according to their most striking manifestation, and are, 
11 
in decreasing order of severity, hydrops fetalis, icterus 
II 
'I I, 
li 
li i! p 
il 
1: 
II 
li,l 
gravis:neonatorum, and congenital anemia of the newborn. 
The icterus type is the most ~requent. 
I , 
The diagnosis is made on the basis of clinical 
features noted above and is substantiated by the findings 
II of an Rhf father and fetus and an Rh- mother whose serum 
rj 
/i contains anti-Rh antibodies. 
'I 
1: 
Treatment consists primarily of early and, if 
[j necessary, repeated Rh- blood transfusions and the 
ii ji administration of oxygen and parenteral vitamih K, calcium 
.I 
i' 
/1 glucona te '·· and glucose and saline. 
I! ,I 
!! As a preventive measure, all girls and women in the 
"' i\ child-bearing age who are Rh- should be transfused only withi, 
- - ===c.c··=·t~ -,_____ -=----=,--- -~- -- -- '-- -••--c=-==~-=- --~=------ 1 
!I 
lr 
:I 
: 
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!i 
:1 compatible Rh- blood. 
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